Abstract:The serine-threonine kinase, tumor progression locus 2 (Tpl2, also known as Map3k8/Cot), is a potent inflammatory mediator that drives the production of TNFα, IL-1β, and IFNγ. We previously demonstrated that Tpl2 regulates TCR signaling and modulates T helper cell differentiation. However, very little is known about how Tpl2 modulates the development of regulatory T cells (Tregs). Tregs are a specialized subset of T cells that express FoxP3 and possess immunosuppressive properties to limit excess inflammation. Because of the documented role of Tpl2 in promoting inflammation, we hypothesized that Tpl2 antagonizes Treg development and immunosuppressive function. Herein, we demonstrate that Tpl2 constrains the development of inducible Tregs (iTregs). Tpl2 naïve CD4 T cells preferentially develop into FoxP3 iTregs in vitro as well as in vivo in a murine model of OVAinduced systemic tolerance. Treg biasing of Tpl2 T cells depended upon the TCR signal strength and corresponded with reduced activation of the mammalian target of rapamycin (mTOR) pathway. Importantly, Tpl2 Tregs have basally increased expression of FoxP3 and immunosuppressive molecules, IL-10 and cytotoxic T lymphocyteassociated protein 4 (CTLA-4). Furthermore, they were more immunosuppressive in vivo in a T cell transfer model of colitis, as evidenced by reducing effector T cell accumulation, systemic production of inflammatory cytokines, and colonic inflammation. These results demonstrate that Tpl2 promotes inflammation in part by constraining FoxP3 expression and Treg immunosuppressive functions. Overall these findings suggest that Tpl2 inhibition could be used to preferentially drive Treg induction and thereby limit inflammation in a variety of autoimmune diseases. INTRODUCTION Pathogenesis of a number of autoimmune diseases is attributed to self-reactive T cells that recognize self-antigens and trigger organ-specific damage (1). Regulatory T cells are a specialized lineage of T cells with immunosuppressive properties. The forkhead box P3 (FoxP3) transcription factor is important in specifying this lineage (2,3), and humans with mutations in the Foxp3 gene develop severe multi-organ autoimmune disease including autoimmune enteropathy, dermatitis, thyroiditis, and type I diabetes (4). This syndrome is highly homologous to that observed in scurfy mice that also harbor mutations within the Foxp3 gene (5). Tregs arise naturally in the thymus (natural Tregs, nTregs or thymus-derived Tregs, tTregs) or can be induced from naïve conventional T cells in the periphery (inducible Tregs; iTregs) (6-9). Both types of FoxP3 Tregs exhibit critical immunoregulatory functions to maintain central and peripheral http://www.jbc.org/cgi/doi/10.1074/jbc.M116.718783 The latest version is at JBC Papers in Press. Published on June 3, 2016 as Manuscript M116.718783 Copyright 2016 by The American Society for Biochemistry and Molecular Biology, Inc. by gest on N ovem er 8, 2017 hp://w w w .jb.org/ D ow nladed from

CREB determines the expression of ST2 in Tregs and mediates the balance between type 1 and type 2 immune responses

Cyclic AMP-Responsive Element-Binding Protein (CREB) is Critical in Autoimmunity by Promoting Th17 but Inhibiting Treg Cell Differentiation

STING trafficking activates MAPK-CREB signaling to trigger regulatory T cell differentiation

Foxp3 Enhancers Synergize to Maximize Regulatory T Cell Suppressive Capacity.

A distal Foxp3 enhancer enables interleukin-2 dependent thymic Treg cell lineage commitment for robust immune tolerance

FOXP3 Exon 2 Controls Treg Stability and Autoimmunity

FOXP3 exon 2 controls T reg stability and autoimmunity

Targeted Demethylation of FOXP3-TSDR Enhances the Suppressive Capacity of STAT6-deficient Inducible T Regulatory Cells

Nemo-like Kinase Drives Foxp3 Stability and is Critical for Maintenance of Immune Tolerance by Regulatory T Cells.

Treg Expression of CIS Suppresses Allergic Airway Inflammation Through Antagonizing an Autonomous TH2 Program.

T cell receptor signaling controls Foxp3 expression via PI3K, Akt, and mTOR

Tumor progression locus 2 ( Tpl 2 ) activates the mTOR pathway , inhibits FoxP 3 expression and limits Treg immunosuppressive functions

Suppression of Tumorigenicity 2 (st2) Signaling is Required for Regulatory T Cell Control of Graft-Vs. Host Disease

Deciphering regulation of FOXP3 expression in human conventional T cells

Inhibition of the JAK/STAT Signaling Pathway in Regulatory T Cells Reveals a Very Dynamic Regulation of Foxp3 Expression

Pim-2 Kinase Influences Regulatory T Cell Function and Stability by Mediating Foxp3 Protein N-terminal Phosphorylation

Novel Foxo1-dependent Transcriptional Programs Control Treg Cell Function

Sirtuin2 suppresses the polarization of regulatory T cells toward T helper 17 cells through repressing the expression of signal transducer and activator of transcription 3 in a mouse colitis model

DNA demethylation switches the drivers of Foxp3 expression to maintain regulatory T cell identity

The ubiquitin ligase Stub1 negatively modulates regulatory T cell suppressive activity by promoting degradation of the transcription factor Foxp3

Control of Regulatory T Cells and T Helper Cells in Human Diseases: from Bench to Bedside.